{
    "organizations": [],
    "uuid": "b5d50fc352ccfee0047d6b2a7db84f629a6b6610",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medigen-vaccine-biologics-to-issue/brief-medigen-vaccine-biologics-to-issue-18-3-mln-new-shares-for-working-capital-supplement-idUSL4N1PI4D9",
    "ord_in_thread": 0,
    "title": "BRIEF-Medigen Vaccine Biologics to issue 18.3 mln new shares for working capital supplement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Medigen Vaccine Biologics Corp :\n* Says it plans to issue 18.3 million new shares with par value of T$10 per share and tentative issue price at T$27 per share for working capital supplement\n* Says 2,742,000 new shares will be offered to the companyâ€™s employees, remaining 15,540,000 shares will be offered via public offering\nSource text in Chinese: goo.gl/c486UT\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-23T19:33:00.000+02:00",
    "crawled": "2018-01-24T15:48:12.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "medigen",
        "vaccine",
        "biologics",
        "corp",
        "say",
        "plan",
        "issue",
        "million",
        "new",
        "share",
        "par",
        "value",
        "per",
        "share",
        "tentative",
        "issue",
        "price",
        "per",
        "share",
        "working",
        "capital",
        "supplement",
        "say",
        "new",
        "share",
        "offered",
        "company",
        "employee",
        "remaining",
        "share",
        "offered",
        "via",
        "public",
        "offering",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}